nach oben

Journal of Gastroenterology

Erschienen in:

25.11.2016 | Review

Intestinal stem cell transplantation

verfasst von: Tetsuya Nakamura, Mamoru Watanabe

Erschienen in: Journal of Gastroenterology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Organoid technologies to expand intestinal epithelial cells are gaining increasing attention as a useful tool to investigate many aspects of intestinal epithelial biology and pathology. One important application of organoid systems would be to use intestinal epithelial cells expanded in culture for following transplantation experiments. In this article, we present a brief overview of the studies that have succeeded in generating new epithelial tissues in the surface of native intestines in mice by organoid transplantation. We also discuss possible applications of this experimental approach in basic research on the intestinal epithelium as well as in regenerative medicine for various types of intestinal diseases in humans.

Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–5.CrossRefPubMed

Sato T, Stange DE, Ferrante M, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011;141:1762–72.CrossRefPubMed

Jung P, Sato T, Merlos-Suárez A, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med. 2011;17:1225–7.CrossRefPubMed

Yui S, Nakamura T, Sato T, et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nat Med. 2012;18:618–23.CrossRefPubMed

Wang F, Scoville D, He XC, et al. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology. 2013;145:383–395.CrossRefPubMedPubMedCentral

Fordham RP, Yui S, Hannan NR, et al. Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell. 2013;13:734–44.CrossRefPubMedPubMedCentral

Miyoshi H, Stappenbeck TS. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat Protoc. 2013;8:2471–82.CrossRefPubMedPubMedCentral

Sato T, Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science. 2013;340:1190–4.CrossRefPubMed

Kretzschmar K, Clevers H. Organoids: modeling development and the stem cell niche in a dish. Dev Cell. 2016;38:590–600.CrossRefPubMed

10.

Bartfeld S. Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids. Dev Biol. 2016. doi:10.1016/j.ydbio.2016.09.014.PubMed

11.

Schweiger PJ, Jensen KB. Modeling human disease using organotypic cultures. Curr Opin Cell Biol. 2016;43:22–9.CrossRefPubMed

12.

Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586–97.CrossRefPubMed

13.

Evans GS, Flint N, Somers AS, et al. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci. 1992;101(Pt 1):219–31.PubMed

14.

Fukamachi H. Proliferation and differentiation of fetal rat intestinal epithelial cells in primary serum-free culture. J Cell Sci. 1992;103(Pt 2):511–9.PubMed

15.

Sato T, van Es JH, Snippert HJ, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–8.CrossRefPubMed

16.

Rothenberg ME, Nusse Y, Kalisky T, et al. Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. Gastroenterology. 2012;142(1195–1205):e1196.

17.

Sasaki N, Sachs N, Wiebrands K, et al. Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon. Proc Natl Acad Sci USA. 2016;113:5399–407.CrossRef

18.

Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol. 2016;18:246–54.CrossRefPubMed

19.

Date S, Sato T. Mini-gut organoids: reconstitution of the stem cell niche. Annu Rev Cell Dev Biol. 2015;31:269–89.CrossRefPubMed

20.

Kedinger M, Simon-Assmann PM, Lacroix B, et al. Fetal gut mesenchyme induces differentiation of cultured intestinal endodermal and crypt cells. Dev Biol. 1986;113:474–83.CrossRefPubMed

21.

Del Buono R, Fleming KA, Morey AL, et al. A nude mouse xenograft model of fetal intestine development and differentiation. Development. 1992;114:67–73.PubMed

22.

Duluc I, Freund JN, Leberquier C, et al. Fetal endoderm primarily holds the temporal and positional information required for mammalian intestinal development. J Cell Biol. 1994;126:211–21.CrossRefPubMed

23.

Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15:19–33.CrossRefPubMed

24.

Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell. 2013;154:274–84.CrossRefPubMed

25.

Tait IS, Evans GS, Flint N, et al. Colonic mucosal replacement by syngeneic small intestinal stem cell transplantation. Am J Surg. 1994;167:67–72.CrossRefPubMed

26.

Avansino JR, Chen DC, Woolman JD, et al. Engraftment of mucosal stem cells into murine jejunum is dependent on optimal dose of cells. J Surg Res. 2006;132:74–9.CrossRefPubMed

27.

Avansino JR, Chen DC, Hoagland VD, et al. Orthotopic transplantation of intestinal mucosal organoids in rodents. Surgery. 2006;140:423–34.CrossRefPubMed

28.

Avansino JR, Chen DC, Hoagland VD, et al. Treatment of bile acid malabsorption using ileal stem cell transplantation. J Am Coll Surg. 2005;201:710–20.CrossRefPubMed

29.

Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541–6.CrossRefPubMed

30.

Okabe M, Ikawa M, Kominami K, et al. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett. 1997;407:313–9.CrossRefPubMed

31.

Snippert HJ, van der Flier LG, Sato T, et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell. 2010;143:134–44.CrossRefPubMed

32.

Fukuda M, Mizutani T, Mochizuki W, et al. Small intestinal stem cell identity is maintained with functional Paneth cells in heterotopically grafted epithelium onto the colon. Genes Dev. 2014;28:1752–7.CrossRefPubMedPubMedCentral

33.

van der Flier LG, Haegebarth A, Stange DE, et al. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137:15–7.CrossRefPubMed

34.

van der Flier LG, van Gijn ME, Hatzis P, et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 2009;136:903–12.CrossRefPubMed

35.

Robine S, Jaisser F, Louvard D. Epithelial cell growth and differentiation. IV. controlled spatiotemporal expression of transgenes: new tools to study normal and pathological states. Am J Physiol. 1997;273:G759–62.PubMed

36.

Gierut JJ, Jacks TE, Haigis KM. Strategies to achieve conditional gene mutation in mice. Cold Spring Harb Protoc. 2014;2014:339–49.PubMedPubMedCentral

37.

Kagnoff MF. The intestinal epithelium is an integral component of a communications network. J Clin Invest. 2014;124:2841–3.CrossRefPubMedPubMedCentral

38.

Vereecke L, Beyaert R, van Loo G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med. 2011;17:584–93.CrossRefPubMed

39.

Kedinger M, Duluc I, Fritsch C, et al. Intestinal epithelial-mesenchymal cell interactions. Ann N Y Acad Sci. 1998;859:1–17.CrossRefPubMed

40.

McLin VA, Henning SJ, Jamrich M. The role of the visceral mesoderm in the development of the gastrointestinal tract. Gastroenterology. 2009;136:2074–91.CrossRefPubMed

41.

Spence JR, Lauf R, Shroyer NF. Vertebrate intestinal endoderm development. Dev Dyn. 2011;240:501–20.CrossRefPubMedPubMedCentral

42.

Cahan P, Li H, Morris SA, et al. Cell Net: network biology applied to stem cell engineering. Cell. 2014;158:903–15.CrossRefPubMedPubMedCentral

43.

Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature. 2011;475:390–3.CrossRefPubMed

44.

Morris SA, Cahan P, Li H, et al. Dissecting engineered cell types and enhancing cell fate conversion via Cell Net. Cell. 2014;158:889–902.CrossRefPubMedPubMedCentral

Titel: Intestinal stem cell transplantation
verfasst von: Tetsuya Nakamura
Mamoru Watanabe
Publikationsdatum: 25.11.2016
Verlag: Springer Japan
Erschienen in: Journal of Gastroenterology / Ausgabe 2/2017
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI: https://doi.org/10.1007/s00535-016-1288-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Intestinal stem cell transplantation

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels

Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis

Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?

Nonalcoholic fatty liver disease in Asia: emerging perspectives

Factors influencing the accuracy of EUS FNA: do educational elements matter?

Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin